Clinical Trials Regulatory and Funding Information by EU-LAC PerMed

28 July 2023 – One of the activities of the EU-LAC PerMed project was the Virtual Helpdesk for clinical trials regulatory and funding information. It aimed to provide information on regulatory and funding agencies regarding clinical trials in Latin America and Europe, and to facilitate the establishment of partnerships in clinical trials on Personalised Medicine across countries and regions. This information is now available as a report for download.

This document organizes and summarizes all the data collected during the activity of the EU-LAC PerMed Virtual Helpdesk, a tool which has been developed during the lifetime of the EU-LAC project.

By publishing the information in a downloadable report (pdf) format, EU-LAC PerMed wants to enable that the project’s results and outputs will continue to be usable and available for future stakeholders identified withing the project: health professionals, scientists, policy-makers, general public and other stakeholders including pan-European infrastructures and Research Organisations.

The report is available here.

The EU-LAC PerMed project – Widening EU-CELAC policy and research cooperation in Personalised Medicine- was launched in January 2019 and ended in December 2022. Funded by the Horizon 2020 Programme of the European Commission, it has been implemented by a bi-regional consortium of eleven organizations from ten countries (Spain, Germany, Brazil, Italy, Chile, France, Uruguay, Panama, Israel, and Argentina).

EU-LAC PerMed aimed to promote and raise awareness of Personalised Medicine, fostering dialogue and cooperation between EU and LAC (Latin American and Caribbean) countries in this field.